logo
logo

Rarebase Announces Promotion of Chris Moxham To President

Jul 13, 2023•about 2 years ago

Position

President

Company

Rarebase

Chris Moxham
Palo AltoBiotechnologyHealth CareTherapeuticsArtificial Intelligence

Description

Rarebase, a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and capital efficiency, today announced the promotion of Chris Moxham, Ph.D., to the newly created role of President effective immediately. In addition to continuing to serve as Chief Scientific Officer, Moxham will be responsible for driving the company’s strategic plan for growth.

Company Information

Company

Rarebase

Location

Palo Alto, California, United States

About

Rarebase is enabling a better life for the 400 million people living with rare disease. With a product engine designed to discover treatments for hundreds of monogenic diseases simultaneously, Rarebase is focused on the largest untapped drug discovery opportunity in human health: rare diseases. Rarebase has already uncovered potential treatments for hundreds of rare diseases. The company has also built a “drug-gene atlas” to enable AI-driven drug discovery.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months